You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR COLISTIMETHATE SODIUM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for colistimethate sodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01025921 ↗ Tracheobronchitis Prevention Trial Completed University of Thessaly N/A 2009-11-01 We aim to study whether the use of inhaled antibiotics may have an impact on the incidence of tracheobronchitis and pneumonia associated with the use of mechanical ventilation. The investigators hypothesize that this could be possible by decreasing the population of gram negative germs that colonize the lumen of tracheal tube and upper airways.
NCT01400750 ↗ Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis Completed Universitaire Ziekenhuizen Leuven Phase 4 2001-08-01 Treatment of new Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) can postpone chronic infection. Aim of the study: compare 2 Pa eradication regimens in children with new Pa infection.
NCT01449838 ↗ Phase I Study of Colistin Methanesulfonate Sodium Completed GlaxoSmithKline Phase 1 2010-10-23 This is a clinical study protocol for a single centre, randomized, double blind, placebo controlled, single and repeat dose study to investigate the safety, tolerability and pharmacokinetics of intravenous dosing of Colistin Methanesulfonate Sodium (CMS-Na) in healthy Japanese male subjects. Eighteen subjects will receive CMS-Na 2.5mg/kg (as colistin activity or 75,000 IU/kg) or placebo as a single dose and twice daily for 2.5 days by intravenous infusion. Blood and urine samples for pharmacokinetics analysis will be taken at regular intervals after dosing. Safety will be assessed by measurement of vital signs, Echocardiogram (ECGs), safety laboratory data, renal function and review of adverse events.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for colistimethate sodium

Condition Name

Condition Name for colistimethate sodium
Intervention Trials
Pneumonia 3
Non Cystic Fibrosis Bronchiectasis 2
Gram-Negative Bacterial Infections 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for colistimethate sodium
Intervention Trials
Pneumonia 7
Infections 5
Infection 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for colistimethate sodium

Trials by Country

Trials by Country for colistimethate sodium
Location Trials
United States 28
Greece 9
Italy 6
Israel 6
Australia 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for colistimethate sodium
Location Trials
California 3
Ohio 2
New York 2
Michigan 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for colistimethate sodium

Clinical Trial Phase

Clinical Trial Phase for colistimethate sodium
Clinical Trial Phase Trials
Phase 4 5
Phase 3 6
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for colistimethate sodium
Clinical Trial Phase Trials
Completed 12
Recruiting 2
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for colistimethate sodium

Sponsor Name

Sponsor Name for colistimethate sodium
Sponsor Trials
Zambon SpA 2
University of Thessaly 2
Universitaire Ziekenhuizen Leuven 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for colistimethate sodium
Sponsor Trials
Other 16
Industry 7
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.